Henry Schein Inc reports results for the quarter ended June 30 - Earnings Summary
Henry Schein Inc reports results for the quarter ended June 30 - Earnings Summary
Henry Schein Inc HSIC.OQ reported quarterly adjusted earnings of $1.27 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.10. The mean expectation of eighteen analysts for the quarter was for earnings of $1.24 per share. Wall Street expected results to range from $1.17 to $1.39 per share.
Revenue rose 6.7% to $3.46 billion from a year ago; analysts expected $3.37 billion.
Henry Schein Inc's reported EPS for the quarter was 82 cents.
The company reported quarterly net income of $94 million.
Henry Schein Inc shares had risen by 3.6% this quarter and gained 14.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Henry Schein Inc is $88.50, about 2.2% above its last closing price of $86.51
This summary was machine generated from LSEG data August 4 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.24 | 1.27 | Beat |
Mar. 31 2026 | 1.22 | 1.32 | Beat |
Dec. 31 2025 | 1.30 | 1.34 | Beat |
Sep. 30 2025 | 1.28 | 1.38 | Beat |
Recent news on Henry Schein
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Henry Schein falls after naming new CFO
Brief: Henry Schein Announces Chief Financial Officer Transition
Brief: Henry Schein - Increases Revolving Credit Commitments To $1.25 Billion, Extends Termination To Sept 19, 2031